Navigation Links
Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 - 2017)
Date:1/23/2013

etitive analysis.

The Global Epigenetics market is showing a double digit growth (CAGR 25%) due to supportive factors such as, (i) huge amount of funds and investments, (ii) increasing partnerships and collaborations, and (iii) rapid screening tools. Epigenetics is used in the identification of new epigenetic biomarkers, which will aid in better diagnosis and prognosis of diseases. While there are factors favoring the market growth, there are concerns such as change in re-imbursement systems and lack of predictive markers holding back the growth of this market. However, the positive aspects in this field may very well offset the market restraints to aid the market grow at an exceptional rate.

The report also profiles leading participants of this industry with their recent developments and other strategic industry activities. These include: CH3 BioSystems (U.S.), Eisai (Japan), Covaris Inc. (U.S.), Epiontis (Germany), RiboMed Biotechnologies (U.S.), 4SC (Germany), Novus Biologicals (U.S.), Merck Millipore (U.S.), CellCentric (U.K.), Celgene (U.S.), Karus Therapeutics (U.K.), EpiTherapeutics (Denmark), Resverlogix (Canada), Epizyme (U.S.), Glaxosmithkline (U.K.), Epigenomics (Germany).

Scope of the Report This technology report categorizes the market for epigenetics by geographical region (including the important countries in each region), applications, and epigenetic mechanisms, forecasting the market value in revenue by analyzing the current and future trends in research, diagnostics and therapeutics industries.

A detailed description of the global technology developments and evolving trends in the epigenetics field with key prominence on research innovations, collaborative efforts and focused research through consortiums dedicated for epigenetics.

A close view on the drug de
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Epigenetics R&D Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumber Other Classes of Epigenetic Targets
2. Premier Cancer Centers Dallas opens up a new world of groundbreaking and life-saving technology
3. GenScript Announces Joint Road Show with Open Monoclonal Technology, Inc.
4. AAIPharma Expands Laboratory Service Offerings and Capabilities in its Technology Center
5. GenScript anuncia un programa conjunto con Open Monoclonal Technology, Inc.
6. GenScript kündigt gemeinsame Roadshow mit Open Monoclonal Technology, Inc. an
7. GenScript anuncia una muestra itinerante conjunta con Open Monoclonal Technology, Inc.
8. GenScript Anuncia Exposição Itinerante Junto com a Open Monoclonal Technology, Inc.
9. Block Engineering Announces Collaborative Agreement with Pfizer for Next Generation Cleaning Verification Technology
10. Zimmer Receives FDA Clearance for Revolutionary New Surgical Guidance Technology
11. Government Hospitals in Ecuador Continue to Invest in Integrity Life Sciences Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015 Zimmer Holdings, Inc. ... today announced that its Board of Directors has approved the ... second quarter of 2015. The cash dividend of ... 14, 2015, to stockholders of record as of the close ... are subject to approval of the Board of Directors and ...
(Date:5/5/2015)... Silver Creek Pharmaceuticals, Inc. announced today the ... from the National Institute of Health (NIH). ... based biotechnology company that discovers and develops ... disease. This award will be used to advance their ... a heart attack. Silver Creek,s Smart Growth ...
(Date:5/5/2015)... 2015  Trovagene, Inc. (NASDAQ:  TROV), a developer ... results for the three months ended March 31, ... we presented favorable clinical results at ASCO GI, ... our Precision Cancer Monitoring platform,s ability to detect ... lung cancers," said Antonius Schuh, Ph.D., chief executive ...
Breaking Medicine Technology:Silver Creek Pharmaceuticals Awarded NIH SBIR Grant for Smart Growth Factor Technology 2Trovagene, Inc. Announces First Quarter 2015 Financial Results 2Trovagene, Inc. Announces First Quarter 2015 Financial Results 3Trovagene, Inc. Announces First Quarter 2015 Financial Results 4Trovagene, Inc. Announces First Quarter 2015 Financial Results 5Trovagene, Inc. Announces First Quarter 2015 Financial Results 6
... MORGANTOWN, W.Va., Jan. 11, 2011 A Blanchette ... the Journal of Neuroscience reveals underlying causes for ... identifies promising pharmaceutical solutions for the devastating condition ... the United States. The BRNI study is the ...
... Jan. 11, 2011 Hill-Rom Holdings, Inc. (NYSE: ... on Wednesday, January 26, 2011.  The company will host a ... 8 a.m. EST. Earnings Release:   Hill-Rom,s ... December 31, 2010, will be issued to the public after ...
Cached Medicine Technology:The Blanchette Rockefeller Neurosciences Institute Identifies Groundbreaking New Therapies for Prevention and Treatment of Alzheimer's Disease 2The Blanchette Rockefeller Neurosciences Institute Identifies Groundbreaking New Therapies for Prevention and Treatment of Alzheimer's Disease 3Hill-Rom Holdings, Inc. Hosts Fiscal 2011 First Quarter Earnings Webcast 2
(Date:5/6/2015)... In celebration of their twentieth anniversary, ... they will give away a deluxe human hair lace wig ... steps to enter on a third-party giveaway tool. The important ... can be the winner. , The hair is a crown, ... destination for such a jewel for the past 20 years. ...
(Date:5/6/2015)... 06, 2015 Qualidigm , ... has hired healthcare executive Ann Olson, RN, BSN, ... will lead Qualidigm’s growing home healthcare services and ... improve the quality, safety, and cost-effectiveness of healthcare ... from Interim HealthCare of North Haven, Inc., a ...
(Date:5/6/2015)... Pass, OR (PRWEB) May 06, 2015 ... for maintaining eye health as we age, is fully ... the Sharon Kleyne Hour™ Power of Water® radio show. ... the need to drink sufficient water each day. As ... Nature’s Tears® EyeMist® for dry eye, Kleyne has extensive ...
(Date:5/6/2015)... 2015 Chinese technology company, Elink-IOT, has ... to raise AUD$150,000 to finalize development of Watcher, the ... smart watch designed to help the owner keep track ... when the item is out of range. , ... the wearer and sends alerts on its E-paper display, ...
(Date:5/6/2015)... LINET Americas has been awarded the ... small business category. The award was given for outstanding ... is given on an annual basis to foreign owned ... to philanthropy. Since 1998, the Charlotte International Cabinet ... Mayor’s International Community Awards. The award was presented to ...
Breaking Medicine News(10 mins):Health News:PremierLaceWigs.com Human Hair Lace Wigs Giveaway Could Change Your Hairstyle 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 3Health News:National Eye Institute’s Eye Care as You Age report endorsed by fresh water advocate Sharon Kleyne – with one addition 2Health News:National Eye Institute’s Eye Care as You Age report endorsed by fresh water advocate Sharon Kleyne – with one addition 3Health News:Crowdfunding campaign Launched for World’s First Anti-Loss Smart Watch 2Health News:LINET Americas Wins The Mayor's International Community Award in Charlotte 2
... Dec. 10 N3 Oceanic, Inc. announced the addition of ... developed by cardiologist Dr. Jeffrey Shapiro, MD, Assistant Professor of ... and NYU Langone Medical Center, who has been giving the ... life-changing results. Dr. Shapiro states, Orosine is the most significant ...
... Global Med Technologies(R), Inc.,("Global Med" or the "Company") ... technology company, today announced that due to,inquiries from ... that was,received from Victory Park Capital Advisors, LLC ... Global Med,s Board of Directors to investigate various,business ...
... Botanical Council (ABC) has officially launched its Adopt-an-Herb program, ... ( Camellia sinensis ). For the next three years, ... ensure that abstracts (summaries) of the latest published scientific ... ABC,s HerbMedPro database, one of the most robust and ...
... Dec. 10 Genomma Lab Internacional,S.A.B. de C.V. (BMV: ... ("OTC") pharmaceuticals and personal care products company,announced today its ... growth without considering acquisitions in the range of 21% ... the range of 27% - 28%. These estimates,are ...
... stress of the economy,have you pulling your hair out? ... Now is the time to take a breather, rejuvenate, ... emotionally,physically and financially, which is why many spas are offering ... get the other half off,there is something for everyone. ...
... Dec. 10 Napo Pharmaceuticals, Inc. ("Napo"),is pleased ... for the license of crofelemer for all indications ... Japan, and certain,indications worldwide. Crofelemer is Napo,s ... 3 trial for the treatment of,chronic diarrhea in ...
Cached Medicine News:Health News:Res-Q Gains Rights To Market Orosine - a Breakthrough, Patented, Natural Heart Supplement That Cardiologists Are Calling the 'Ultimate Cardio Protection' Against Heart Attacks, Strokes and Heart Failure. 2Health News:Global Med Technologies(R), Inc. Clarifies Proposal Received from Victory Park Capital Advisors, LLC 2Health News:Tea Dragon Films is First Adopter in the American Botanical Council's New Adopt-An-Herb Program 2Health News:Tea Dragon Films is First Adopter in the American Botanical Council's New Adopt-An-Herb Program 3Health News:Tea Dragon Films is First Adopter in the American Botanical Council's New Adopt-An-Herb Program 4Health News:Genomma Lab Announces 2009 Earnings Guidance 2Health News:Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals 2Health News:Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals 3Health News:Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals 4Health News:Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals 5
The Midas II Stainer is an automated slide stainer designed for use in hematology and microbiology laboratories....
... an "assembly-line worker" for routine staining protocols ... Programmable continuous slide stainer for routine stains. ... in short time. Its large number of ... working principle provides a high throughput. A ...
Cholesterol, Total. An automated analyzer test kits....
Intended for the quantitative determination of total cholesterol in serum. Reaction: Endpoint. Reaction complete within five minutes. Wavelength: 500 nm. Linearity: 700 mg/dL (18.1 mmol/L). Single st...
Medicine Products: